SCHEMBL13639699

SCHEMBL13639699

Bc1nccc2c(C(=O)C(=O)N3CCN(C(=O)c4ccccn4)C[C@@H]3C)c[nH]c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 5/20 0.59
CYP2D6 P10635 4/20 0.59
CYP2C9 P11712 3/20 0.59
CYP3A4 P08684 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.42
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
GHSR Q92847 3/20 0.39
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PLA2G1B P04054 1/20 0.35
ATG4B Q9Y4P1 1/20 0.35
HTT P42858 1/20 0.35
RBP4 P02753 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9942600 1.00 CYP2C19 (0.59) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL9942592 0.91 CYP2C19 (0.59) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL1763486 0.90 CYP2C19 (0.58) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL2633365 0.90 CYP2C19 (0.58) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL1763427 0.90 CYP2C19 (0.58) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL9942598 0.89 CYP2C19 (0.71) CYP2C19CYP2D6CYP2C9CYP3A4L3MBTL1
SCHEMBL9942597 0.84 CYP2C19 (0.51) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL1763586 0.84 CYP2C19 (0.50) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL1762986 0.84 CYP2C19 (0.50) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL2633386 0.84 CYP2C19 (0.50) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363705-B9 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2012-11-07 EP disclosed